Insulin options in type 2 diabetes following market discontinuation of Mixtard® 30

Insulin options in type 2 diabetes following market discontinuation of Mixtard® 30
DPC Vol 12 Issue 3 2010
Type 2 diabetes is a progressive condition that in many cases ultimately requires treatment with insulin to ensure good glycaemic control. A number of...  
Read full article